Sort by
Refine Your Search
-
Category
-
Field
-
17 Apr 2024 Job Information Organisation/Company Institut Curie - Research Center Department Research Research Field Medical sciences » Cancer research Researcher Profile Recognised Researcher (R2
-
10 Apr 2024 Job Information Organisation/Company Institut Curie - Research Center Research Field Medical sciences » Cancer research Researcher Profile Recognised Researcher (R2) Country France
-
“Chemistry and Modelling for Biology of Cancer” at Institut Curie (Orsay) in will be supervised by Dr Guillaume Bort. The project consists in synthesizing theranostic prodrugs for cancer treatment, adapted
-
21 Mar 2024 Job Information Organisation/Company Institut Curie - CNRS Research Field Chemistry Biological sciences » Biology Researcher Profile Recognised Researcher (R2) Leading Researcher (R4
-
Institut Curie is a key player in the fight against cancer, combining an internationally renowned Research center with a state-of-the-art Hospital complex. Founded in 1909 by Marie Curie, Institut
-
scientific environment and collaborative culture of the Institut Curie, its Research center and its hospital which are focused on breast cancer, as well as the numerous surrounding research institutes located
-
. The Institut Curie research center, located in the center of Paris, is an internationally renowned research institution bringing together physicists, chemists, biologists, bioinformaticians and clinicians. Jean
-
experimentalist physicist or biophysicist to work on a cell mechanics project as part of the European "Pushing Cell" project at the CNRS laboratory "Physics of Cells and Cancer" at the Institut Curie in P
-
. Integrated within the PSL University, and close to other major institutions such as the Ecole Normale Supérieure and the Institut Curie, the Collège de France constitutes an exceptional scientific environment
-
Département de Chimie Moléculaire (equipe I2BM) / Laboratoire Interdisciplinaire de physique (équipe BIOP) | Grenoble, Rhone Alpes | France | 3 months ago
interactions with DNA. Inthis context, we have recently shown, in collaboration with the Institut Curie in Orsay, that this commercial antibody (iMab) is not specificfor i-motif DNA but also binds to cytosine